EU regulator finds possible blood clot link with J&J vaccine, but says benefits outweigh risks
The European Medicines Agency said Tuesday the Johnson & Johnson Covid-19 vaccine has possible links to rare blood clot incidents.
Full Article
EU regulator finds possible blood clot link with J&J vaccine, but says benefits outweigh risks
Upworthy
0 shares
2 views
You might like
Related news coverage
US health panel reviews J&J vaccine pause over rare clots
SeattlePI.com
With the U.S. pause of Johnson & Johnson’s COVID-19 vaccine stretched into a second week, authorities are weighing whether to..
-
EU agency says people should get 2nd dose of AstraZeneca too
SeattlePI.com
-
EU agency to issue more guidance on AstraZeneca's COVID shot
SeattlePI.com
-
EMA Says Benefits Outweigh The Clots Potentially Linked To Johnson & Johnson Vaccine
NPR
-
EU agency links Johnson & Johnson shot to rare clots, says odds favor use
PIX 11
Advertisement
More coverage
Johnson & Johnson jumps as vaccine shipments to Europe set to resume after regulator says benefits outweigh blood clot risks
Business Insider
Johnson & Johnson shares climbed Tuesday as the drug maker restarts shipments of its coronavirus vaccine to the European Union.
-
EMA Says J&J Covid Vaccine's Benefits Outweigh Rare Blood Clot Risks
RTTNews
-
E.U. regulator finds possible link between J&J Covid vaccine and blood clots
Upworthy
-
EU regulator backs use of Johnson & Johnson COVID-19 vaccine despite finding possible link to blood clots
CBC.ca
-
Alert: European regulator says benefits of Johnson & Johnson vaccine outweigh risks despite 'possible link" to rare blood clots
SeattlePI.com